Back to search
FDAFDA · Food and drugs·Recall number D-0280-2022

Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50

Published December 22, 2021 · Recall initiated: October 12, 2021

Summary

FDA records drug Class I recall D-0280-2022, published December 22, 2021 and initiated October 12, 2021. Recalling firm: Teligent Pharma, Inc.; Status: Terminated; Reported quantity: 52,104 glass bottles; Lot: Lot #: 13262, Exp. 03/2022; 14217, Exp. 08/2022. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teligent Pharma, Inc.
Distributor
Nationwide within the United States
Lot
Lot #: 13262, Exp. 03/2022; 14217, Exp. 08/2022
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50 recalled?

Yes. FDA published recall D-0280-2022 on December 22, 2021. Reported hazard: Superpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Press Release